Multiple sclerosis (MS) is a chronic autoimmune disease in which the immune system attacks the body’s nerves. Immune cells will breakdown the myelin sheath around the nerve fibers that help transport ...
Multiple sclerosis (MS) affects the brain and spinal cord limiting movement, vision, and others. Known as an autoimmune disorder, this chronic disease of the central nervous system slows or blocks ...
Multiple sclerosis, which affects around one in 500 people in Switzerland, is an autoimmune disease in which immune cells attack the central nervous system, causing irreversible damage. Current ...
A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.
The Epstein-Barr virus (EBV) is so common that most people pick it up at some point, often as “mono,” and then forget about ...
Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple sclerosis (MS), a chronic autoimmune disease that affects nearly one million ...
One of the leading triggers for multiple sclerosis (MS) is an infection with the Epstein-Barr virus. However, certain gene variants also play an important role. Researchers at the University of Zurich ...
Proteins (evasin) from tick saliva could help treat multiple sclerosis and cancer by suppressing the inflammation and paving the way for new treatments.
A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.
A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results